114 related articles for article (PubMed ID: 27061542)
1. Aberrant promoter methylation of SOCS-1 gene may contribute to the pathogenesis of hepatocellular carcinoma: a meta-analysis.
Zhao RC; Zhou J; He JY; Wei YG; Qin Y; Li B
J BUON; 2016; 21(1):142-51. PubMed ID: 27061542
[TBL] [Abstract][Full Text] [Related]
2. Association of APC, GSTP1 and SOCS1 promoter methylation with the risk of hepatocellular carcinoma: a meta-analysis.
Liu M; Cui LH; Li CC; Zhang L
Eur J Cancer Prev; 2015 Nov; 24(6):470-83. PubMed ID: 25853848
[TBL] [Abstract][Full Text] [Related]
3. Role of RASSF1A promoter methylation in the pathogenesis of hepatocellular carcinoma: a meta-analysis of 21 cohort studies.
Li YS; Xie Q; Yang DY; Zheng Y
Mol Biol Rep; 2014 Jun; 41(6):3925-33. PubMed ID: 24566681
[TBL] [Abstract][Full Text] [Related]
4. Correlation between promoter methylation in the GSTP1 gene and hepatocellular carcinoma development: a meta-analysis.
Li QF; Li QY; Gao AR; Shi QF
Genet Mol Res; 2015 Jun; 14(2):6762-72. PubMed ID: 26125884
[TBL] [Abstract][Full Text] [Related]
5. Methylation status of suppressor of cytokine signaling-1 gene in hepatocellular carcinoma.
Miyoshi H; Fujie H; Moriya K; Shintani Y; Tsutsumi T; Makuuchi M; Kimura S; Koike K
J Gastroenterol; 2004 Jun; 39(6):563-9. PubMed ID: 15235874
[TBL] [Abstract][Full Text] [Related]
6. Methylation-mediated silencing of SOCS-1 gene in hepatocellular carcinoma derived from cirrhosis.
Okochi O; Hibi K; Sakai M; Inoue S; Takeda S; Kaneko T; Nakao A
Clin Cancer Res; 2003 Nov; 9(14):5295-8. PubMed ID: 14614012
[TBL] [Abstract][Full Text] [Related]
7. Role of P14 and MGMT gene methylation in hepatocellular carcinomas: a meta-analysis.
Li CC; Yu Z; Cui LH; Piao JM; Liu M
Asian Pac J Cancer Prev; 2014; 15(16):6591-6. PubMed ID: 25169493
[TBL] [Abstract][Full Text] [Related]
8. Role of RASSF1A promoter methylation in the pathogenesis of ovarian cancer: a meta-analysis.
Si JG; Su YY; Han YH; Chen RH
Genet Test Mol Biomarkers; 2014 Jun; 18(6):394-402. PubMed ID: 24665911
[TBL] [Abstract][Full Text] [Related]
9. CpG island hypermethylation of SOCS-1 gene is inversely associated with HBV infection in hepatocellular carcinoma.
Ko E; Kim SJ; Joh JW; Park CK; Park J; Kim DH
Cancer Lett; 2008 Nov; 271(2):240-50. PubMed ID: 18639978
[TBL] [Abstract][Full Text] [Related]
10. Meta-analysis of DNA methylation biomarkers in hepatocellular carcinoma.
Zhang C; Li J; Huang T; Duan S; Dai D; Jiang D; Sui X; Li D; Chen Y; Ding F; Huang C; Chen G; Wang K
Oncotarget; 2016 Dec; 7(49):81255-81267. PubMed ID: 27835605
[TBL] [Abstract][Full Text] [Related]
11. Role of CDH1 promoter methylation in colorectal carcinogenesis: a meta-analysis.
Li YX; Lu Y; Li CY; Yuan P; Lin SS
DNA Cell Biol; 2014 Jul; 33(7):455-62. PubMed ID: 24684676
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic alteration of the SOCS1 gene in hepatocellular carcinoma.
Chu PY; Yeh CM; Hsu NC; Chang YS; Chang JG; Yeh KT
Swiss Med Wkly; 2010; 140():w13065. PubMed ID: 20648401
[TBL] [Abstract][Full Text] [Related]
13. [Aberrant methylation of multiple genes and its clinical implication in hepatocellular carcinoma].
Lou C; Yang B; Gao YT; Wang YJ; Nie FH; Yuan Q; Zhang CL; Du Z
Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):831-6. PubMed ID: 19173828
[TBL] [Abstract][Full Text] [Related]
14. Methylation-mediated gene silencing of suppressor of cytokine signaling-1 (SOCS-1) gene in esophageal squamous cell carcinoma patients of Kashmir valley.
Hussain S; Singh N; Salam I; Bandil K; Yuvaraj M; Akbar Bhat M; Muzaffar Mir M; Siddiqi MA; Sobti RC; Bharadwaj M; Das BC
J Recept Signal Transduct Res; 2011 Apr; 31(2):147-56. PubMed ID: 21385099
[TBL] [Abstract][Full Text] [Related]
15. Ubiquitous activation of Ras and Jak/Stat pathways in human HCC.
Calvisi DF; Ladu S; Gorden A; Farina M; Conner EA; Lee JS; Factor VM; Thorgeirsson SS
Gastroenterology; 2006 Apr; 130(4):1117-28. PubMed ID: 16618406
[TBL] [Abstract][Full Text] [Related]
16. Promoter methylation of DAPK gene may contribute to the pathogenesis of nonsmall cell lung cancer: a meta-analysis.
Li FF; Yang Y; Wang XL; Hong YY; Wang NF; Chen ZD
Tumour Biol; 2014 Jun; 35(6):6011-20. PubMed ID: 24659425
[TBL] [Abstract][Full Text] [Related]
17. Promoter methylation of the RASSF1A gene may contribute to colorectal cancer susceptibility: a meta-analysis of cohort studies.
Wang HL; Liu P; Zhou PY; Zhang Y
Ann Hum Genet; 2014 May; 78(3):208-16. PubMed ID: 24621386
[TBL] [Abstract][Full Text] [Related]
18. Aberrant promoter methylation of HIN-1 gene may contribute to the pathogenesis of breast cancer: a meta-analysis.
Dai D; Dong XH; Cheng ST; Zhu G; Guo XL
Tumour Biol; 2014 Aug; 35(8):8209-16. PubMed ID: 24850174
[TBL] [Abstract][Full Text] [Related]
19. Hypermethylation of suppressor of cytokine signaling 1 in hepatocellular carcinoma patients.
Saelee P; Chuensumran U; Wongkham S; Chariyalertsak S; Tiwawech D; Petmitr S
Asian Pac J Cancer Prev; 2012; 13(7):3489-93. PubMed ID: 22994783
[TBL] [Abstract][Full Text] [Related]
20. Aberrant promoter methylation of the CHD1 gene may contribute to the pathogenesis of breast cancer: a meta-analysis.
Gu X; Xue JQ; Zhu X; Ye MS; Zhang WH
Tumour Biol; 2014 Sep; 35(9):9395-404. PubMed ID: 24952891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]